U of Guelph prof discovers plant-based solution to target leukemia weakness
Peer-Reviewed Publication
Updates every hour. Last Updated: 22-Jun-2026 05:15 ET (22-Jun-2026 09:15 GMT/UTC)
Hundreds of genes have been linked to autism, yet the precise molecular and cellular mechanisms behind it remain largely unclear. A new study published in Nature, led by Gaia Novarino at the Institute of Science and Technology Austria (ISTA), aims to uncover these mechanisms—and in doing so, might lay the groundwork for developing medical therapies.
New Oxford University-led research reveals that bees can regulate their feeding to avoid over-consuming certain essential nutrients - and that honeybees make a specialist “baby food” that gives their larvae a better-balanced diet.
Cells have surface receptors that couple to proteins and other molecules to initiate or inhibit certain behaviors. Typically, the number of these receptors increases as the cell matures, but researchers have now identified that one receptor influences cell behavior much earlier than previously thought and appears to help trigger the cell differentiation process to form neurons.
MD4SB will establish an infrastructure for the dynamic description of biological macromolecules, connecting three major European Research Infrastructures (Instruct-ERIC, ELIXIR, and EU-OPENSCREEN ERIC) with three of Europe's largest supercomputing centres (BSC-CNS, CINECA, and JSC).
The project will facilitate the use of molecular simulations to understand how biomacromolecules function, advance the molecular description of diseases, and accelerate drug discovery.
Coordinated by IRB Barcelona, the project brings together 25 partners across 8 countries and incorporates Almirall, Sanofi, and other pharmaceutical companies to provide feedback and evaluate the practical usefulness of the platform in industrial settings. The IRB Barcelona spin-off company Nostrum Biodiscovery will bridge the gap between academic groups and pharmaceutical companies.